These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32085934)

  • 1. Predicted heart mass-based size matching among recipients with moderate pulmonary hypertension: Outcomes and sex effect.
    Shah M; Saeed O; Shin J; Murthy S; Sims DB; Vukelic S; Goldstein D; Forest SJ; Jorde UP; Patel SR
    J Heart Lung Transplant; 2020 Jul; 39(7):648-656. PubMed ID: 32085934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size matching in heart transplantation: Is predicted heart mass the optimal method in a United Kingdom cohort?
    Cheshire C; Kydd A; Nerlekar N; Catarino P; Brown A; Parameshwar J; Pettit S
    Clin Transplant; 2021 Mar; 35(3):e14192. PubMed ID: 33336378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting oversized donor cardiac allografts for patients with pulmonary hypertension may be unnecessary.
    Kwon MH; Wong S; Kittleson M; Ardehali A; Laks H; Shemin RJ; Kobashigawa J
    Transplant Proc; 2014 Jun; 46(5):1497-501. PubMed ID: 24935319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension.
    Tedford RJ; Beaty CA; Mathai SC; Kolb TM; Damico R; Hassoun PM; Leary PJ; Kass DA; Shah AS
    J Heart Lung Transplant; 2014 Mar; 33(3):289-97. PubMed ID: 24462554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular undersizing is associated with increased 1-year mortality.
    Kawabori M; Critsinelis AC; Hironaka CE; Chen FY; Zhan Y; Thayer KL; Couper GS
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1048-1059.e3. PubMed ID: 33485653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of predicted heart mass-based size matching on survival after heart transplantation in Korea: Analysis of the Korean Organ Transplant Registry.
    Yoon M; Oh J; Lee CJ; Park JJ; Cho HJ; Choi JO; Jung SH; Lee HY; Choi DJ; Kim JJ; Jeon ES; Kang SM
    J Heart Lung Transplant; 2022 Dec; 41(12):1751-1760. PubMed ID: 36216692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database.
    Patel ND; Weiss ES; Nwakanma LU; Russell SD; Baumgartner WA; Shah AS; Conte JV
    Circulation; 2008 Sep; 118(14 Suppl):S83-8. PubMed ID: 18824775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing predicted heart mass size matching in obese heart transplant recipients.
    Kim ST; Helmers MR; Iyengar A; Smood B; Herbst DA; Patrick WL; Han JJ; Altshuler P; Atluri P
    J Heart Lung Transplant; 2021 Aug; 40(8):805-813. PubMed ID: 34127356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor and Recipient Size Matching in Heart Transplantation With Predicted Heart and Lean Body Mass.
    Miller RJH; Hedman K; Amsallem M; Tulu Z; Kent W; Fatehi-Hassanabad A; Clarke B; Heidenreich P; Hiesinger W; Khush KK; Teuteberg J; Haddad F
    Semin Thorac Cardiovasc Surg; 2022; 34(1):158-167. PubMed ID: 33444763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis.
    Vakil K; Duval S; Sharma A; Adabag S; Abidi KS; Taimeh Z; Colvin-Adams M
    Int J Cardiol; 2014 Oct; 176(3):595-9. PubMed ID: 25305706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total ventricular mass oversizing +50% or greater was a predictor of worse 1-year survival after heart transplantation.
    Kawabori M; Critsinelis AC; Patel S; Nordan T; Thayer KL; Chen FY; Couper GS
    J Thorac Cardiovasc Surg; 2023 Oct; 166(4):1145-1154.e9. PubMed ID: 35688717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of reversible pulmonary hypertension on outcomes after heart transplantation.
    Drakos SG; Kfoury AG; Gilbert EM; Horne BD; Long JW; Stringham JC; Campbell BA; Renlund DG
    J Heart Lung Transplant; 2007 Apr; 26(4):319-23. PubMed ID: 17403471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Predicted Heart Mass-Based Donor-Recipient Size Matching on Transplant Outcomes.
    Gliozzi G; Loforte A; Mariani C; Cavalli GG; Botta L; Santamaria V; Tassi S; Martìn-Suarez S; Potena L; Pacini D
    Transplant Proc; 2022 Apr; 54(3):774-781. PubMed ID: 35279307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
    Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
    J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.
    Erickson KW; Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Zucker MJ; Pifarré R; Lawless CE; Robinson JA; Scanlon PJ
    J Heart Transplant; 1990; 9(5):526-37. PubMed ID: 2231091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
    Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oversized allograft is associated with improved survival after lung transplantation for idiopathic pulmonary arterial hypertension.
    Eberlein M; Diehl E; Bolukbas S; Merlo CA; Reed RM
    J Heart Lung Transplant; 2013 Dec; 32(12):1172-8. PubMed ID: 23876630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Transpulmonary Artery Gradient Obtained at the Time of Left Ventricular Assist Device Implantation Negatively Affects Survival After Cardiac Transplantation.
    Uriel N; Imamura T; Sayer G; Agarwal R; Sims DB; Takayama H; John R; Pagani FD; Naka Y; Sundareswaran KS; Farrar DJ; Jorde UP;
    J Card Fail; 2019 Oct; 25(10):777-784. PubMed ID: 30904557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does recipient work status pre-transplant affect post-heart transplant survival? A United Network for Organ Sharing database review.
    Ravi Y; Lella SK; Copeland LA; Zolfaghari K; Grady K; Emani S; Sai-Sudhakar CB
    J Heart Lung Transplant; 2018 May; 37(5):604-610. PubMed ID: 29482932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.